Medicamen Biotech consolidated net profit declines 3.31% in the September 2024 quarter

Net profit of Medicamen Biotech declined 3.31% to Rs 1.46 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales rose 2.76% to Rs 44.74 crore in the quarter ended September 2024 as against Rs 43.54 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	44.74	43.54	3
OPM %	11.87	10.66	-
PBDT	4.56	4.29	6
PBT	1.96	2.46	-20
NP	1.46	1.51	-3